Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 52201-52250 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT05026983
Binimetinib and Encorafenib for the Treatment of Metastatic Melanoma and Central Nervous System Metastases
PHASE2Recruiting
35 participants
Started: Dec 27, 2021 · Completed: Feb 2, 2027
3 conditions1 sponsor1 location
NCT04883671
Stereotactic Body Radiotherapy (SBRT) for Early Treatment of Oligometastatic Adenoid Cystic Carcinoma: The SOLAR Trial
NARecruiting
32 participants
Started: Dec 27, 2021 · Completed: Jun 1, 2030
2 conditions3 sponsors5 locations
NCT05773638
Cardiovascular and Venous Thromboembolism Disease in Patients with Von Willebrand Disease in the French West
N/ARecruiting
100 participants
Started: Dec 26, 2021 · Completed: Dec 26, 2026
1 condition1 sponsor6 locations
NCT06279611
An Evaluation of LY007 Cell Injection for r/r B-NHL
PHASE1Recruiting
18 participants
Started: Dec 25, 2021 · Completed: May 31, 2026
1 condition3 sponsors1 location
NCT06364852
An Evaluation of LY007 Cell Injection for r/r B-NHL
PHASE1Recruiting
18 participants
Started: Dec 25, 2021 · Completed: May 31, 2026
1 condition3 sponsors1 location
NCT05762991
Application of Artificial Intelligence on the Diagnosis of Helicobacter Pylori Infection and Premalignant Gastric Lesion
N/ARecruiting
2,000 participants
Started: Dec 24, 2021 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT05171166
Neoadjuvant HAIC of TACE Plus Donafenib in BCLC B Stage HCC: a Multi-center Randomized Controlled Trial.
PHASE2/PHASE3Recruiting
156 participants
Started: Dec 24, 2021 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT05175053
Early RRT in AKI After Cardiac Surgery
NARecruiting
202 participants
Started: Dec 24, 2021 · Completed: Sep 30, 2028
1 condition2 sponsors2 locations
NCT04733378
Impact of Surgical Timing on the Neurodevelopmental Prognosis of Newborns With Complex Congenital Heart Disease
NARecruiting
50 participants
Started: Dec 24, 2021 · Completed: Dec 24, 2025
1 condition1 sponsor1 location
NCT05170542
The Neoadjuvant Treatment of Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma.
PHASE2Recruiting
42 participants
Started: Dec 24, 2021 · Completed: Jan 24, 2026
1 condition1 sponsor1 location
NCT05665179
Removing Barriers: Community Partnering for Innovative Solutions to the Opioid Crisis
NARecruiting
800 participants
Started: Dec 23, 2021 · Completed: Jul 31, 2025
6 conditions2 sponsors2 locations
NCT05013255
Pioglitazone Therapy Targeting Fatigue in Breast Cancer
PHASE2Recruiting
30 participants
Started: Dec 23, 2021 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT05803993
Fecal Microbiota Transplantation to Relieve Symptoms of Irritable Bowel Syndrome With Constipation
NARecruiting
35 participants
Started: Dec 23, 2021 · Completed: Dec 23, 2025
1 condition1 sponsor1 location
NCT05146349
Minnesota RETAIN Impact Evaluation
NARecruiting
3,200 participants
Started: Dec 23, 2021 · Completed: Feb 28, 2026
1 condition5 sponsors1 location
NCT05257135
A Clinico-biological Database in Cachexia in Patients With Colon Cancer
NARecruiting
150 participants
Started: Dec 23, 2021 · Completed: May 31, 2029
1 condition1 sponsor1 location
NCT04886726
PTCY Plus uhCG/EGF for Graft Versus Host Disease Prophylaxis
PHASE1Recruiting
18 participants
Started: Dec 23, 2021 · Completed: Nov 30, 2027
1 condition1 sponsor1 location
NCT05803980
Fecal Microbiota Transplantation to Relieve Symptoms of Irritable Bowel Syndrome Without Constipation
NARecruiting
35 participants
Started: Dec 23, 2021 · Completed: Dec 23, 2025
1 condition1 sponsor1 location
NCT05385887
Antibiotic Treatment foLlowing Surgical drAinage of Perianal abScess; the ATLAS Trial
NARecruiting
298 participants
Started: Dec 23, 2021 · Completed: Aug 1, 2025
3 conditions2 sponsors11 locations
NCT04942067
APG-2575 in Combination With Novel Therapeutic Regimens in Subjects With Relapsed or Refractory Multiple Myeloma
PHASE1/PHASE2Recruiting
108 participants
Started: Dec 23, 2021 · Completed: Dec 1, 2024
2 conditions1 sponsor3 locations
NCT05103046
First in Human Study of UCT-03-008 in Participants With Advanced Solid Tumors
PHASE1Recruiting
68 participants
Started: Dec 23, 2021 · Completed: Dec 15, 2025
1 condition2 sponsors5 locations
NCT06071195
All-in-One Prostate Cancer Staging with MRI
N/ARecruiting
400 participants
Started: Dec 22, 2021 · Completed: Aug 22, 2026
1 condition3 sponsors3 locations
NCT05626348
The Clinical Efficacy of Immunomodulators in RA Patients
PHASE4Recruiting
400 participants
Started: Dec 22, 2021 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06059885
Tislelizumab Plus TKI as Adjuvant Therapy Versus Active Surveillance in Patients With HCC
PHASE2Recruiting
60 participants
Started: Dec 22, 2021 · Completed: Dec 20, 2025
1 condition1 sponsor1 location
NCT04631471
Regeneration in Cervical Degenerative Myelopathy
PHASE3Recruiting
400 participants
Started: Dec 22, 2021 · Completed: Sep 1, 2026
2 conditions1 sponsor1 location
NCT05127226
HALOS: A Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of Multiple Ascending Doses of ION582 in Participants With Angelman Syndrome
PHASE1/PHASE2Recruiting
70 participants
Started: Dec 22, 2021 · Completed: Mar 31, 2029
1 condition1 sponsor11 locations
NCT05188092
Lung Ultrasound-Guided Fluid Deresuscitation in ICU Patients
NARecruiting
1,000 participants
Started: Dec 22, 2021 · Completed: Dec 1, 2025
4 conditions2 sponsors3 locations
NCT06420843
Microbiota, Metabolome and Nutrition: an 'Artificially Intelligent' Way to Personalized Nutrition
NARecruiting
48 participants
Started: Dec 22, 2021 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05191381
Immune Modulation by Exosomes in COVID-19
N/ARecruiting
40 participants
Started: Dec 22, 2021 · Completed: Dec 31, 2026
4 conditions1 sponsor1 location
NCT05166850
Preventative Intervention for Cholera for 7 Days
NARecruiting
2,900 participants
Started: Dec 22, 2021 · Completed: Dec 31, 2025
3 conditions3 sponsors2 locations
NCT05051891
A Randomized, Open-label, Multi-center, Phase III Study of Orelabrutinib in Combination With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) vs. R-CHOP Alone in Patients With Treatment-naїve Mantle Cell Lymphoma
PHASE3Recruiting
356 participants
Started: Dec 22, 2021 · Completed: Dec 31, 2027
1 condition1 sponsor22 locations
NCT05117619
The HOME Program for Individuals With Traumatic Brain Injury and Family Members
NARecruiting
440 participants
Started: Dec 22, 2021 · Completed: May 30, 2026
1 condition5 sponsors1 location
NCT06856993
Early Evaluation of Exosome Multiomics and Clinical Prognosis in Patients With Sudden Death
N/ARecruiting
300 participants
Started: Dec 22, 2021 · Completed: Dec 31, 2026
3 conditions1 sponsor1 location
NCT05184816
A Study of Deferoxamine (DFO) in People With Leptomeningeal Metastasis
PHASE1Recruiting
35 participants
Started: Dec 22, 2021 · Completed: Dec 31, 2025
1 condition3 sponsors7 locations
NCT05890456
Students With Involved Families and Teachers
NARecruiting
320 participants
Started: Dec 22, 2021 · Completed: Jun 30, 2026
3 conditions1 sponsor1 location
NCT04965519
A Study of RC48-ADC for the Treatment of HER2-expressing Gynecological Malignancies
PHASE2Recruiting
120 participants
Started: Dec 21, 2021 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT05209620
Orelabrutinib Combined With Pemetrexed For Relapsed/Refractory Central Nervous System Lymphoma
PHASE2Recruiting
30 participants
Started: Dec 21, 2021 · Completed: Dec 21, 2026
1 condition1 sponsor1 location
NCT04947384
Pulmonary Vascular Hemodynamics Before and After Mitral Valve Procedures
N/ARecruiting
120 participants
Started: Dec 21, 2021 · Completed: Jan 20, 2026
1 condition1 sponsor1 location
NCT04997811
Repurposed Drugs to Improve Haematological Responses in Myelodysplastic Syndromes
PHASE2Recruiting
120 participants
Started: Dec 21, 2021 · Completed: Jun 30, 2025
1 condition6 sponsors19 locations
NCT05098613
Preliminary Safety and Tolerability of CD19x22 CAR T Cells in Adolescent and Adult R/R B-NHL Patients
PHASE1Recruiting
20 participants
Started: Dec 21, 2021 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05800925
Triage Survey for Psychiatry Research Eligibility
N/ARecruiting
2,000 participants
Started: Dec 21, 2021 · Completed: Dec 31, 2025
3 conditions1 sponsor3 locations
NCT06323278
Effectiveness of Cognitive Stimulation Treatment in Patients With Parkinson's Disease
N/ARecruiting
68 participants
Started: Dec 21, 2021 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT05553886
S086 Tablets for Chronic Heart Failure With Reduced Ejection Fraction
PHASE3Recruiting
5 participants
Started: Dec 21, 2021 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05068544
Adolescent Normative Sport Movement Analysis
N/ARecruiting
40 participants
Started: Dec 21, 2021 · Completed: Dec 31, 2024
2 conditions1 sponsor1 location
NCT05115474
Study of Screening Brain MRIs in Stage IV Breast Cancer
N/ARecruiting
170 participants
Started: Dec 21, 2021 · Completed: Oct 31, 2026
3 conditions2 sponsors2 locations
NCT05979675
Acute Myeloid Leukemia Registry
N/ARecruiting
250 participants
Started: Dec 21, 2021 · Completed: Dec 21, 2026
1 condition1 sponsor1 location
NCT06124599
Prodromes of Menstrual Staphylococcal Toxic Shock
N/ARecruiting
316 participants
Started: Dec 21, 2021 · Completed: Dec 21, 2026
1 condition1 sponsor1 location
NCT05621343
New Strategies for Assessment of the Persistence of Viable Bacilli in Latent and Active Tuberculosis
N/ARecruiting
130 participants
Started: Dec 21, 2021 · Completed: Dec 31, 2024
3 conditions1 sponsor1 location
NCT05521503
Biopsy Collection and Repository Database
N/ARecruiting
400 participants
Started: Dec 21, 2021 · Completed: Dec 31, 2030
1 condition1 sponsor1 location
NCT05074420
A Study of Baricitinib (LY3009104) in Children With COVID-19
PHASE3Recruiting
24 participants
Started: Dec 21, 2021 · Completed: May 31, 2026
2 conditions1 sponsor14 locations
NCT05154799
Developmental Coordination Disorder
NARecruiting
280 participants
Started: Dec 21, 2021 · Completed: Jan 21, 2027
2 conditions1 sponsor1 location